Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia

Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Antiviral Agents / supply & distribution
  • Betacoronavirus / pathogenicity
  • COVID-19
  • China / epidemiology
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / mortality
  • Critical Illness / mortality
  • Drug Dosage Calculations
  • Humans
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / adverse effects
  • Methylprednisolone / therapeutic use
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / pathology
  • Practice Guidelines as Topic
  • Respiration, Artificial
  • Respiratory Distress Syndrome / complications*
  • Respiratory Distress Syndrome / drug therapy*
  • Respiratory Distress Syndrome / mortality
  • Respiratory Distress Syndrome / pathology
  • SARS-CoV-2
  • Salvage Therapy
  • Shock, Septic / complications*
  • Shock, Septic / drug therapy*
  • Shock, Septic / mortality
  • Shock, Septic / pathology

Substances

  • Adrenal Cortex Hormones
  • Antiviral Agents
  • Methylprednisolone